Homburger has advised ADC Therapeutics SA.ADC Therapeutics SA, a commercial-stage biotechnology company listed on the NYSE, has completed a private placement transaction totaling USD 100 million….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
